About
Advisor who is president, CEO and co-founder of Tallac Therapeutics and was previously CSO and founding management at ALX Oncology. She earlier held leadership roles at Pfizer and Wyeth Research.
Colleagues at Lightstone Ventures
Brendan Kelly
Principal at Lightstone Ventures
Caroline Gaynor
Partner at Lightstone Ventures
Christina Isacson
Partner at Lightstone Ventures
Christina Isacson, Ph.D.
Partner at Lightstone Ventures
Doug Treco
Advisor at Lightstone Ventures
Doug Treco, Ph.D.
Advisor at Lightstone Ventures
Frank D. Lee
Advisor at Lightstone Ventures
H. Martin Seidel
Advisor at Lightstone Ventures